Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Biocon up as unit's eye drug to be launched in Canada by mid-2025

** Shares of Biocon up 3.3% at 286.2 rupees
    ** Co says unit Biocon Biologics' visual impairment
treatment drug Yesafili to launch in Canada by July 1, 2025
    ** Stock set for best day in about two weeks if trend holds
    ** Including BION, nine out of 20 stocks on Nifty Pharma
 .NIPHARM  rated "hold" on avg; rest "buy" or higher and Divi's
Labs  DIVI.NS  only "sell"-rated stock - LSEG data
    ** BION and NIPHARM each rose for four straight months in
Feb

 (Reporting by Varun Vyas in Bengaluru)
 ((varunvyas.hebbalalu@thomsonreuters.com))

Recent news on Divi's Laboratories

See all news